• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫相关 lncRNA 可预测急性髓系白血病的预后。

Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.

机构信息

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Children Health Care, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, China.

出版信息

Cancer Med. 2022 Feb;11(3):888-899. doi: 10.1002/cam4.4487. Epub 2021 Dec 14.

DOI:10.1002/cam4.4487
PMID:34904791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8817083/
Abstract

The immune microenvironment in acute myeloid leukemia (AML) is closely related to patients' prognosis. Long noncoding RNAs (lncRNAs) are emerging as key regulators in immune systems. In this study, we established a prognostic model using an immune-related lncRNA (IRL) signature to predict AML patients' overall survival (OS) through Least Absolute Shrinkage and Selection Operator (LASSO) and multivariate Cox regression analysis. Kaplan-Meier analysis, receiver operating characteristic (ROC) analysis, univariate Cox regression, and multivariate Cox regression analyses further illustrated the reliability of our prognostic model. An IRL signature-based nomogram consisting of other clinical features efficiently predicted the OS of AML patients. The incorporation of the IRL signature improved the ELN2017 risk stratification system's prognostic accuracy. In addition, we found that monocytes and metabolism-related pathways may play a role in AML progression. Overall, the IRL signature appears as a novel effective model for evaluating the OS of AML patients and may be implemented to contribute to the prolonged OS in AML patients.

摘要

急性髓系白血病(AML)中的免疫微环境与患者的预后密切相关。长链非编码 RNA(lncRNA)作为免疫系统的关键调节因子而备受关注。本研究通过最小绝对值收缩和选择算子(LASSO)和多变量 Cox 回归分析,建立了一个基于免疫相关 lncRNA(IRL)特征的预后模型,以预测 AML 患者的总生存期(OS)。Kaplan-Meier 分析、受试者工作特征(ROC)分析、单变量 Cox 回归和多变量 Cox 回归分析进一步说明了我们预后模型的可靠性。一个由其他临床特征组成的基于 IRL 特征的列线图可以有效地预测 AML 患者的 OS。IRL 特征的纳入提高了 ELN2017 风险分层系统的预后准确性。此外,我们发现单核细胞和代谢相关途径可能在 AML 进展中发挥作用。总的来说,IRL 特征似乎是评估 AML 患者 OS 的一种新的有效模型,可能有助于延长 AML 患者的 OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/2d370a7c6ff6/CAM4-11-888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/9b2a3c34684f/CAM4-11-888-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/d1db40c6129c/CAM4-11-888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/181ccf2d7dbb/CAM4-11-888-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/18eb8dd96748/CAM4-11-888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/77296aed66b0/CAM4-11-888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/9d07697285e1/CAM4-11-888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/2d370a7c6ff6/CAM4-11-888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/9b2a3c34684f/CAM4-11-888-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/d1db40c6129c/CAM4-11-888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/181ccf2d7dbb/CAM4-11-888-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/18eb8dd96748/CAM4-11-888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/77296aed66b0/CAM4-11-888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/9d07697285e1/CAM4-11-888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d7e/8817083/2d370a7c6ff6/CAM4-11-888-g002.jpg

相似文献

1
Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.免疫相关 lncRNA 可预测急性髓系白血病的预后。
Cancer Med. 2022 Feb;11(3):888-899. doi: 10.1002/cam4.4487. Epub 2021 Dec 14.
2
Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.鉴定七个新型铁死亡相关长非编码 RNA 特征作为急性髓系白血病的诊断生物标志物。
BMC Med Genomics. 2021 Sep 27;14(1):236. doi: 10.1186/s12920-021-01085-9.
3
Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.铜死亡相关 lncRNA 特征可预测急性髓系白血病患者的预后。
BMC Bioinformatics. 2023 Feb 3;24(1):37. doi: 10.1186/s12859-023-05148-9.
4
Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.鉴定与急性髓系白血病免疫相关基因和长链非编码 RNA 相关的综合预后特征。
Cancer Invest. 2022 Sep;40(8):663-674. doi: 10.1080/07357907.2022.2096230. Epub 2022 Jul 11.
5
Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia.鉴定 7 个长链非编码 RNA 标志物作为急性髓系白血病的预后生物标志物。
Dis Markers. 2021 Dec 20;2021:8223216. doi: 10.1155/2021/8223216. eCollection 2021.
6
Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.急性髓系白血病中与预后和免疫反应相关的m6A相关长链非编码RNA的鉴定
Front Cell Dev Biol. 2021 Nov 16;9:770451. doi: 10.3389/fcell.2021.770451. eCollection 2021.
7
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.一种新型的铜死亡相关长链非编码RNA特征:对急性髓系白血病的预后和治疗价值
Front Oncol. 2022 Oct 7;12:966920. doi: 10.3389/fonc.2022.966920. eCollection 2022.
8
A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.一种与焦亡相关的长链非编码RNA特征可预测头颈部鳞状细胞癌的预后和免疫微环境。
Int Immunopharmacol. 2021 Dec;101(Pt B):108268. doi: 10.1016/j.intimp.2021.108268. Epub 2021 Oct 20.
9
Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.建立基于肿瘤蛋白 p53 突变的急性髓系白血病预后标志物。
Curr Res Transl Med. 2022 Sep;70(4):103347. doi: 10.1016/j.retram.2022.103347. Epub 2022 Apr 26.
10
Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.系统分析自噬相关特征揭示急性髓系白血病的预后预测因子。
DNA Cell Biol. 2020 Sep;39(9):1595-1605. doi: 10.1089/dna.2020.5667. Epub 2020 Aug 12.

引用本文的文献

1
Prime-time for LncRNA signatures in acute myeloid leukemia?急性髓系白血病中长链非编码RNA特征的黄金时代?
Ann Hematol. 2025 Sep 18. doi: 10.1007/s00277-025-06616-3.
2
The HNRNPC/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia.HNRNPC/CELF2信号通路驱动耐药性急性髓系白血病中的糖酵解重编程和线粒体功能障碍。
Cell Biosci. 2025 May 16;15(1):61. doi: 10.1186/s13578-025-01386-x.
3
Comprehensive analysis of immune-related lncRNAs in AML patients uncovers potential therapeutic targets and prognostic biomarkers.

本文引用的文献

1
LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A.长链非编码 RNA USP30-AS1 通过顺式调控 USP30 和 ANKRD13A 促进急性髓系白血病细胞的存活。
Hum Cell. 2022 Jan;35(1):360-378. doi: 10.1007/s13577-021-00636-7. Epub 2021 Oct 25.
2
Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia.急性髓系白血病RNA结合蛋白相关预后模型的系统构建与验证
Front Genet. 2021 Sep 24;12:715840. doi: 10.3389/fgene.2021.715840. eCollection 2021.
3
Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasis.
对急性髓系白血病(AML)患者免疫相关长链非编码RNA(lncRNA)的综合分析揭示了潜在的治疗靶点和预后生物标志物。
Heliyon. 2024 May 7;10(9):e30616. doi: 10.1016/j.heliyon.2024.e30616. eCollection 2024 May 15.
4
Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients.热休克蛋白与铁死亡相关长链非编码RNA的计算分析以预测急性髓系白血病患者的预后
Front Genet. 2023 Aug 1;14:1218276. doi: 10.3389/fgene.2023.1218276. eCollection 2023.
5
The tip of the iceberg-The roles of long noncoding RNAs in acute myeloid leukemia.冰山一角——长链非编码 RNA 在急性髓系白血病中的作用。
Wiley Interdiscip Rev RNA. 2023 Nov-Dec;14(6):e1796. doi: 10.1002/wrna.1796. Epub 2023 Jun 2.
6
A Novel Prognostic Model for Acute Myeloid Leukemia Based on Gene Set Variation Analysis.一种基于基因集变异分析的急性髓系白血病新型预后模型。
J Oncol. 2022 Nov 21;2022:7727424. doi: 10.1155/2022/7727424. eCollection 2022.
利用生物信息数据库分析和标本验证来鉴定预测胃癌转移的新型生物标志物。
J Cancer. 2021 Aug 13;12(19):5967-5976. doi: 10.7150/jca.58768. eCollection 2021.
4
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.肺腺癌免疫相关长链非编码RNA预后标志物的鉴定与验证
Front Genet. 2021 Jul 5;12:681277. doi: 10.3389/fgene.2021.681277. eCollection 2021.
5
A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.一种用于急性髓系白血病肿瘤免疫微环境评估和预后预测的缺氧风险特征。
Sci Rep. 2021 Jul 19;11(1):14657. doi: 10.1038/s41598-021-94128-1.
6
Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.基于喉鳞状细胞癌 ceRNA 调控网络鉴定预后 lncRNAs。
BMC Cancer. 2021 Jun 15;21(1):705. doi: 10.1186/s12885-021-08422-2.
7
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
8
The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.与 AML 预后相关的基因共表达模块的景观。
J Transl Med. 2021 May 29;19(1):228. doi: 10.1186/s12967-021-02914-2.
9
Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.基于免疫相关基因的急性髓系白血病新型预后模型的建立与验证。
Front Immunol. 2021 May 5;12:639634. doi: 10.3389/fimmu.2021.639634. eCollection 2021.
10
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia.重定向急性髓系白血病中的免疫微环境
Cancers (Basel). 2021 Mar 20;13(6):1423. doi: 10.3390/cancers13061423.